Skip to content

Just another WordPress site

Month: September 2023

Douglas Pharmaceuticals secures US licensing deal to treat high grade cervical dysplasia

Published 27 September 2023

Categorized as Research

Search

Recent Posts

Douglas selected for FDA’s Quality Management Maturity pilot study
R-107 Phase 2 Study Results for Treatment-Resistant Depression Accepted by Leading Scientific Journal, Nature Medicine
Douglas Pharmaceuticals announces the launch of their new Parental Leave Package
Douglas Fiji receives a Recognition Award for Outstanding Achievement at the Prime Minister’s International Business Awards
Douglas Pharmaceuticals expands its Contract Development and Manufacturing (CDMO) business

Recent Comments

No comments to show.

Archives

June 2024
May 2024
December 2023
October 2023
September 2023
August 2023
July 2023
April 2023
February 2023
October 2022
September 2022
June 2021
April 2020
November 2019
May 2019
April 2019
January 2019
December 2018
November 2018

Categories

Awards
Careers
Commercial
Corporate Responsibility
Large Dispensers
Manufacturing
Quality
Research

Douglas

Proudly powered by WordPress.